{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["25-hydroxyvitamin D3-26,23-lactone", "6\u2033-O-acetylglycitin", "Artemisia afra", "Artemisia annua", "angiotensin-converting enzyme 2 (ACE2)", "anti-COVID bioactive compounds", "sesaminol glucoside", "spike (S) glycoprotein", "tryptanthrin"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "39065672", "DateRevised": {"Year": "2024", "Month": "07", "Day": "29"}, "Article": {"Language": ["eng"], "ELocationID": ["821", "10.3390/ph17070821"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "22"}], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "17", "Issue": "7", "PubDate": {"Year": "2024", "Month": "Jun", "Day": "22"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor.", "Abstract": {"AbstractText": ["The expected progress in SARS-CoV-2 vaccinations, as anticipated in 2020 and 2021, has fallen short, exacerbating global disparities due to a lack of universally recognized \"safe and effective\" vaccines. This study focuses on extracts of South African medicinal plants, <i>Artemisia annua</i> and <i>Artemisia afra</i>, to identify metabolomic bioactive compounds inhibiting the binding of the SARS-CoV-2 spike protein to ACE2 receptors. The extracts were monitored for cytotoxicity using a resazurin cell viability assay and xCELLigence real-time cell analyzer. Chemical profiling was performed using UPLC-MS/MS, orthogonal projection to latent structures (OPLS), and evaluated using principle component analysis (PCA) models. Identified bioactive compounds were subjected to in vitro SARS-CoV-2 enzyme inhibition assay using standard methods and docked into the spike (S) glycoprotein of SARS-CoV-2 using Schrodinger<sup>\u00ae</sup> suite followed by molecular dynamics simulation studies. Cell viability assays revealed non-toxic effects of extracts on HEK293T cells at lower concentrations. Chemical profiling identified 81 bioactive compounds, with compounds like 6\u2033-O-acetylglycitin, 25-hydroxyvitamin D3-26,23-lactone, and sesaminol glucoside showing promising binding affinity. Molecular dynamics simulations suggested less stable binding, but in vitro studies demonstrated the ability of these compounds to interfere with SARS-CoV-2 spike protein's binding to the human ACE2 receptor. Sesaminol glucoside emerged as the most effective inhibitor against this interaction. This study emphasizes the importance of multiplatform metabolite profiling and chemometrics to understand plant extract composition. This finding is of immense significance in terms of unravelling metabolomics bioactive compounds inhibiting the binding of the SARS-CoV-2 spike protein to ACE2 receptors and holds promise for phytotherapeutics against SARS-CoV-2."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa."}], "LastName": "Mkolo", "ForeName": "Nqobile Monate", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa."}], "LastName": "Naidoo", "ForeName": "Clarissa Marcelle", "Initials": "CM"}, {"Identifier": ["0000-0001-8695-8137"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Rhodes University, Makhanda 6140, South Africa."}], "LastName": "Kadye", "ForeName": "Rose", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa."}], "LastName": "Obi", "ForeName": "Chikwelu Lawrence", "Initials": "CL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa."}], "LastName": "Iweriebor", "ForeName": "Benson Chucks", "Initials": "BC"}, {"Identifier": ["0000-0002-8004-3187"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa."}], "LastName": "Olaokun", "ForeName": "Oyinlola Oluwunmi", "Initials": "OO"}, {"Identifier": ["0000-0002-3048-4304"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Rhodes University, Makhanda 6140, South Africa."}], "LastName": "Prinsloo", "ForeName": "Earl", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Tadulako, Palu 94118, Indonesia."}], "LastName": "Zubair", "ForeName": "Muhammad Sulaiman", "Initials": "MS"}], "GrantList": [{"GrantID": "RCDI MKOLO NM 21/24", "Agency": "South African Medical Research Council (SAMRC) through its Division of Research Capacity Development", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Wang F., Chen L., Chen H., Yan Z., Liu Y. Discovery of the key active compounds in Citri Reticulatae Pericarpium (Citrus reticulata \u201cChachi\u201d) and their therapeutic potential for the treatment of COVID-19 based on comparative metabolomics and network pharmacology. Front. Pharmacol. 2022;13:1048926. doi: 10.3389/fphar.2022.1048926.", "ArticleIdList": ["10.3389/fphar.2022.1048926", "PMC9727096", "36506534"]}, {"Citation": "Lv Y., Wang S., Liang P., Wang Y., Zhang X., Jia Q., Fu J., Han S., He L. Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach. Anal. Bioanal. Chem. 2021;413:2995\u20133004. doi: 10.1007/s00216-021-03233-7.", "ArticleIdList": ["10.1007/s00216-021-03233-7", "PMC7895511", "33608752"]}, {"Citation": "Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141\u2013154. doi: 10.1038/s41579-020-00459-7.", "ArticleIdList": ["10.1038/s41579-020-00459-7", "PMC7537588", "33024307"]}, {"Citation": "Samprathi M., Jayashree M. Biomarkers in COVID-19: An Up-To-Date Review. Front. Pediatr. 2021;8:607647. doi: 10.3389/fped.2020.607647.", "ArticleIdList": ["10.3389/fped.2020.607647", "PMC8042162", "33859967"]}, {"Citation": "Ciotti M., Angeletti S., Minieri M., Giovannetti M., Benvenuto D., Pascarella S., Sagnelli C., Bianchi M., Bernardini S., Ciccozzi M. COVID-19 Outbreak: An Overview. Chemotherapy. 2019;64:215\u2013222. doi: 10.1159/000507423.", "ArticleIdList": ["10.1159/000507423", "PMC7179549", "32259829"]}, {"Citation": "Rasaily S., Haldipur A.C., Srividya N. Indian red rice phenolic metabolites as potential natural inhibitors of SARS-CoV-2 main protease: A metabolomic and in silico study. Ann. Phytomed. 2021;1:S40\u2013S50. doi: 10.21276/ap.covid19.2021.10.1.5.", "ArticleIdList": ["10.21276/ap.covid19.2021.10.1.5"]}, {"Citation": "Liu J., Xie W., Wang Y., Xiong Y., Chen S., Han J., Wu Q. A comparative overview of COVID-19, MERS and SARS: Review article. Int. J. Surg. 2020;81:1\u20138. doi: 10.1016/j.ijsu.2020.07.032.", "ArticleIdList": ["10.1016/j.ijsu.2020.07.032", "PMC7382925", "32730205"]}, {"Citation": "Rana R., Tripathi A., Kumar N., Ganguly N.K. A Comprehensive Overview on COVID-19: Future Perspectives. Front. Cell. Infect. Microbiol. 2021;11:744903. doi: 10.3389/fcimb.2021.744903.", "ArticleIdList": ["10.3389/fcimb.2021.744903", "PMC8476999", "34595136"]}, {"Citation": "Jackson C.B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 2022;23:3\u201320. doi: 10.1038/s41580-021-00418-x.", "ArticleIdList": ["10.1038/s41580-021-00418-x", "PMC8491763", "34611326"]}, {"Citation": "Oronsky B., Larson C., Hammond T.C., Oronsky A., Kesari S., Lybeck M., Reid T.R. A Review of Persistent Post-COVID Syndrome (PPCS) Clin. Rev. Allergy Immunol. 2023;64:66\u201374. doi: 10.1007/s12016-021-08848-3.", "ArticleIdList": ["10.1007/s12016-021-08848-3", "PMC7896544", "33609255"]}, {"Citation": "Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:869\u2013875. doi: 10.1016/j.dsx.2021.04.007.", "ArticleIdList": ["10.1016/j.dsx.2021.04.007", "PMC9637465", "36351871"]}, {"Citation": "Akindele A.J., Sowemimo A., Agunbiade F.O., Sofidiya M.O., Awodele O., Ade-Ademilua O., Orabueze I., Ishola I.O., Ayolabi C.I., Salu O.B., et al. Bioprospecting for anti-COVID-19 interventions from African medicinal plants: A review. Nat. Prod. Commun. 2022;17:1934578X221096968. doi: 10.1177/1934578X221096968.", "ArticleIdList": ["10.1177/1934578X221096968"]}, {"Citation": "Invernizzi L., Moyo P., Cassel J., Isaacs F.J., Salvino J.M., Montaner L.J., Tietjen I., Maharaj V. Use of hyphenated analytical techniques to identify the bioactive constituents of Gunnera perpensa L., a South African medicinal plant, which potently inhibit SARS-CoV-2 spike glycoprotein-host ACE2 binding. Anal. Bioanal. Chem. 2022;414:3971\u20133985. doi: 10.1007/s00216-022-04041-3.", "ArticleIdList": ["10.1007/s00216-022-04041-3", "PMC9007697", "35419694"]}, {"Citation": "Dwarka D., Agoni C., Mellem J.J., Soliman M.E., Baijnath H. Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches. S. Afr. J. Bot. 2020;133:273\u2013284. doi: 10.1016/j.sajb.2020.07.035.", "ArticleIdList": ["10.1016/j.sajb.2020.07.035", "PMC7437493", "32839635"]}, {"Citation": "Richman D.D. COVID-19 vaccines: Implementation, limitations and opportunities. Glob. Health Med. 2021;3:1\u20135. doi: 10.35772/ghm.2021.01010.", "ArticleIdList": ["10.35772/ghm.2021.01010", "PMC7936373", "33688588"]}, {"Citation": "Chattopadhyay A., Jailani A.A.K., Mandal B. Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness. Vaccines. 2023;11:1347. doi: 10.3390/vaccines11081347.", "ArticleIdList": ["10.3390/vaccines11081347", "PMC10458178", "37631915"]}, {"Citation": "Gillim-Ross L., Subbarao K. Emerging respiratory viruses: Challenges and vaccine strategies. Clin. Microbiol. Rev. 2006;19:614\u2013636. doi: 10.1128/CMR.00005-06.", "ArticleIdList": ["10.1128/CMR.00005-06", "PMC1592697", "17041137"]}, {"Citation": "Ortega-Berlanga B., Pniewski T. Plant-Based Vaccines in Combat against Coronavirus Diseases. Vaccines. 2022;10:138. doi: 10.3390/vaccines10020138.", "ArticleIdList": ["10.3390/vaccines10020138", "PMC8876659", "35214597"]}, {"Citation": "Mehrbod P., Abdalla M.A., Njoya E.M., Ahmed A.S., Fotouhi F., Farahmand B., Gado D.A., Tabatabaian M., Fasanmi O.G., Eloff J.N., et al. South African medicinal plant extracts active against influenza A virus. BMC Complement. Altern. Med. 2018;18:112. doi: 10.1186/s12906-018-2184-y.", "ArticleIdList": ["10.1186/s12906-018-2184-y", "PMC5872571", "29587734"]}, {"Citation": "World Health Organization  WHO Monograph on Good Agricultural and Collection Practices (GACP) for Artemisia annua L. 2006.  [(accessed on 11 January 2024)].  Available online:  https://iris.who.int/bitstream/handle/10665/43509/9241594438_eng.pdf?sequence=1."}, {"Citation": "Kapepula P.M., Kabengele J.K., Kingombe M., Van Bambeke F., Tulkens P.M., Kishabongo A.S., Decloedt E., Zumla A., Tiberi S., Suleman F., et al. Artemisia spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials. Am. J. Trop. Med. Hyg. 2020;103:960\u2013964. doi: 10.4269/ajtmh.20-0820.", "ArticleIdList": ["10.4269/ajtmh.20-0820", "PMC7470522", "32705976"]}, {"Citation": "Bilia A.R., Santomauro F., Sacco C., Bergonzi M.C., Donato R. Essential Oil of Artemisia annua L.: An Extraordinary Component with Numerous Antimicrobial Properties. Evid.-Based Complement. Altern. Med. 2014;2014:159819. doi: 10.1155/2014/159819.", "ArticleIdList": ["10.1155/2014/159819", "PMC3995097", "24799936"]}, {"Citation": "Ferreira J.F., Luthria D.L., Sasaki T., Heyerick A. Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer. Molecules. 2010;15:3135\u20133170. doi: 10.3390/molecules15053135.", "ArticleIdList": ["10.3390/molecules15053135", "PMC6263261", "20657468"]}, {"Citation": "Jackson W.P.U. Origins and Meanings of Names of South African Plant Genera. University of Cape Town UCT Ecolab; Cape Town, South Africa: 1990."}, {"Citation": "Van Wyk B.E., Van Oudtshoorn B., Gerike N. Medicinal Plants of South Africa. Briza Publications; Pretoria, South Africa: 1997. 142p"}, {"Citation": "Liu N.Q., Van der Kooy F., Verpoorte R. Artemisia afra: A potential flagship for African medicinal plants. S. Afr. J. Bot. 2009;75:185\u2013195. doi: 10.1016/j.sajb.2008.11.001.", "ArticleIdList": ["10.1016/j.sajb.2008.11.001"]}, {"Citation": "Motshudi M.C., Olaokun O.O., Mkolo N.M. Evaluation of GC \u00d7 GC-TOF-MS untargeted metabolomics, cytotoxicity and antimicrobial activity of leaf extracts of Artemisia afra (Jacq.) purchased from three local vendors. J. King Saud Univ. Sci. 2021;33:101422. doi: 10.1016/j.jksus.2021.101422.", "ArticleIdList": ["10.1016/j.jksus.2021.101422"]}, {"Citation": "World Health Organization (WHO)  WHO Supports Scientifically-Proven Traditional Medicine. 2020.  [(accessed on 11 January 2024)].  Available online:  https://www.afro.who.int/news/who-supports-scientifically-proven-traditional-medicine."}, {"Citation": "G\u00f6bel S., Kortum F., Chavez K.J., Jordan I., Sandig V., Reichl U., Altomonte J., Genzel Y. Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures. Appl. Microbiol. Biotechnol. 2022;106:4945\u20134961. doi: 10.1007/s00253-022-12027-5.", "ArticleIdList": ["10.1007/s00253-022-12027-5", "PMC9329169", "35767011"]}, {"Citation": "Dolskiy A.A., Grishchenko I.V., Yudkin D.V. Cell Cultures for Virology: Usability, Advantages, and Prospects. Int. J. Mol. Sci. 2020;21:7978. doi: 10.3390/ijms21217978.", "ArticleIdList": ["10.3390/ijms21217978", "PMC7662242", "33121109"]}, {"Citation": "Harcourt J., Tamin A., Lu X., Kamili S., Sakthivel S.K., Murray J., Queen K., Tao Y., Paden C.R., Zhang J., et al. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States. Emerg. Infect. Dis. 2020;26:1266\u20131273. doi: 10.3201/eid2606.200516.", "ArticleIdList": ["10.3201/eid2606.200516", "PMC7258473", "32160149"]}, {"Citation": "Modrof J., Kerschbaum A., Farcet M.R., Niemeyer D., Corman V.M., Kreil T.R. SARS-CoV-2 and the safety margins of cell-based biological medicinal products. Biologicals. 2020;68:122\u2013124. doi: 10.1016/j.biologicals.2020.08.010.", "ArticleIdList": ["10.1016/j.biologicals.2020.08.010", "PMC7456270", "32891497"]}, {"Citation": "O\u2019Brien J., Wilson I., Orton T., Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000;267:5421\u20135426. doi: 10.1046/j.1432-1327.2000.01606.x.", "ArticleIdList": ["10.1046/j.1432-1327.2000.01606.x", "10951200"]}, {"Citation": "Su H.X., Yao S., Zhao W.F., Li M.J., Liu J., Shang W.J., Xie H., Ke C.Q., Hu H.C., Gao M.N., et al. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol. Sin. 2020;41:1167\u20131177. doi: 10.1038/s41401-020-0483-6.", "ArticleIdList": ["10.1038/s41401-020-0483-6", "PMC7393338", "32737471"]}, {"Citation": "Schr\u00f6dinger Release 2020-3: Protein Preparation Wizard. Schr\u00f6dinger; New York, NY, USA: 2020."}, {"Citation": "Sastry G.M., Adzhigirey M., Day T., Annabhimoju R., Sherman W. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 2013;27:221\u2013234. doi: 10.1007/s10822-013-9644-8.", "ArticleIdList": ["10.1007/s10822-013-9644-8", "23579614"]}, {"Citation": "Natesh J., Mondal P., Penta D., Abdul Salam A.A., Meeran S.M. Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation. Comput. Biol. Med. 2021;128:104102. doi: 10.1016/j.compbiomed.2020.104102.", "ArticleIdList": ["10.1016/j.compbiomed.2020.104102", "PMC7606080", "33190011"]}, {"Citation": "Kim I.S. Current perspectives on the beneficial effects of soybean isoflavones and their metabolites on plants. Food Sci. Biotechnol. 2022;31:515\u2013526. doi: 10.1007/s10068-022-01070-7.", "ArticleIdList": ["10.1007/s10068-022-01070-7", "PMC9033921", "35529690"]}, {"Citation": "Boland R., Skliar M., Curino A., Milanesi L. Vitamin D compounds in plants. Plant Sci. 2003;164:357\u2013369. doi: 10.1016/S0168-9452(02)00420-X.", "ArticleIdList": ["10.1016/S0168-9452(02)00420-X"]}, {"Citation": "Aghaee E., Ghodrati M., Ghasemi J.B. In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19) Inform. Med. Unlocked. 2021;23:100516. doi: 10.1016/j.imu.2021.100516.", "ArticleIdList": ["10.1016/j.imu.2021.100516", "PMC7801185", "33457495"]}, {"Citation": "Bepari A.K., Reza H.M. Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation. PeerJ. 2021;9:e11261. doi: 10.7717/peerj.11261.", "ArticleIdList": ["10.7717/peerj.11261", "PMC8051358", "33954055"]}, {"Citation": "Abraham M.J., Murtola T., Schulz R., P\u00e1ll S., Smith J.C., Hess B., Lindahl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19\u201325. doi: 10.1016/j.softx.2015.06.001.", "ArticleIdList": ["10.1016/j.softx.2015.06.001"]}, {"Citation": "Rehman M.T., AlAjmi M.F., Hussain A. Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19. Curr. Pharm. Des. 2021;27:3577\u20133589. doi: 10.2174/1381612826999201116195851.", "ArticleIdList": ["10.2174/1381612826999201116195851", "33200697"]}, {"Citation": "Ogunyemi O.M., Gyebi G.A., Ibrahim I.M., Olaiya C.O., Ocheje J.O., Fabusiwa M.M., Adebayo J.O. Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: A structure-based screening. RSC Adv. 2021;11:33380\u201333398. doi: 10.1039/d1ra05976a.", "ArticleIdList": ["10.1039/d1ra05976a", "PMC9042289", "35497510"]}, {"Citation": "Ahmed N.Z., John Davis G.D., Khan A.A., Prabhakar L., Ram Paratap M., Afnaan Z., Devi Sri M., Anwar N. Arq Aj\u012bb\u2014A wonder Unani formulation for inhibiting SARS-CoV-2 spike glycoprotein and main protease\u2014An in silico approach. J. Complement. Integr. Med. 2021;20:637\u2013649. doi: 10.1515/jcim-2021-0241.", "ArticleIdList": ["10.1515/jcim-2021-0241", "34679263"]}, {"Citation": "Ekowati J., Tejo B.A., Maulana S., Kusuma W.A., Fatriani R., Ramadhanti N.S., Norhayati N., Nofianti K.A., Sulistyowaty M.I., Zubair M.S., et al. Potential Utilization of Phenolic Acid Compounds as Anti-Inflammatory Agents through TNF-\u03b1 Convertase Inhibition Mechanisms: A Network Pharmacology, Docking, and Molecular Dynamics Approach. ACS Omega. 2023;8:46851\u201346868. doi: 10.1021/acsomega.3c06450.", "ArticleIdList": ["10.1021/acsomega.3c06450", "PMC10720000", "38107968"]}, {"Citation": "Zubair M.S., Maulana S., Widodo A., Pitopang R., Arba M., Hariono M. GC-MS, LC-MS/MS, Docking and Molecular Dynamics Approaches to Identify Potential SARS-CoV-2 3-Chymotrypsin-Like Protease Inhibitors from Zingiber officinale Roscoe. Molecules. 2021;26:5230. doi: 10.3390/molecules26175230.", "ArticleIdList": ["10.3390/molecules26175230", "PMC8434146", "34500664"]}, {"Citation": "Mani J.S., Johnson J.B., Steel J.C., Broszczak D.A., Neilsen P.M., Walsh K.B., Naiker M. Natural product-derived phytochemicals as potential agents against coronaviruses: A review. Virus Res. 2020;284:197989. doi: 10.1016/j.virusres.2020.197989.", "ArticleIdList": ["10.1016/j.virusres.2020.197989", "PMC7190535", "32360300"]}, {"Citation": "Tay M.Z., Poh C.M., R\u00e9niam L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: Immunity, inflammation and intervention. Nat. Rev. Immunol. 2020;20:363\u2013374. doi: 10.1038/s41577-020-0311-8.", "ArticleIdList": ["10.1038/s41577-020-0311-8", "PMC7187672", "32346093"]}, {"Citation": "World Health Organization  COVID-19 Vaccine Coverage, World Data. 2023.  [(accessed on 10 April 2024)].  Available online:  https://data.who.int/dashboards/covid19/vaccines?n=c."}, {"Citation": "Ma L.L., Liu H.M., Liu X.M., Yuan X.Y., Xu C., Wang F., Lin J.Z., Xu R.C., Zhang D.K. Screening S protein\u2014ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19. Eur. J. Med. Chem. 2021;226:113857. doi: 10.1016/j.ejmech.2021.113857.", "ArticleIdList": ["10.1016/j.ejmech.2021.113857", "PMC8489279", "34628234"]}, {"Citation": "Arokiyaraj S., Stalin A., Kannan B.S., Shin H. Geranii herba as a Potential Inhibitor of SARS-CoV-2 main 3CLpro, spike RBD, and regulation of unfolded protein response: An in-silico approach. Antibiotics. 2020;9:863. doi: 10.3390/antibiotics9120863.", "ArticleIdList": ["10.3390/antibiotics9120863", "PMC7761775", "33287311"]}, {"Citation": "Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J. Virol. 2020;94:e00127-20. doi: 10.1128/JVI.00127-20.", "ArticleIdList": ["10.1128/JVI.00127-20", "PMC7081895", "31996437"]}, {"Citation": "Bretz G.P.M., Campos J.R., Veloso A.A., Gomes K.B., Fernandes A.B. Impact of COVID-19 pandemic on serum 25-hydroxyvitamin D levels in Brazilian patients. J. Lab. Precis. Med. 2023;8:31. doi: 10.21037/jlpm-23-35.", "ArticleIdList": ["10.21037/jlpm-23-35"]}, {"Citation": "Bae J.H., Choe H.J., Holick M.F., Lim S. Association of vitamin D status with COVID-19 and its severity: Vitamin D and COVID-19: A narrative review. Rev. Endocr. Metab. Disord. 2022;3:579\u2013599. doi: 10.1007/s11154-021-09705-6.", "ArticleIdList": ["10.1007/s11154-021-09705-6", "PMC8724612", "34982377"]}, {"Citation": "Prinsloo S., Rialet P., Carlos C.B. A cell viability assay to determine the cytotoxic Effects of Water contaminated by microbes. S. Afr. J. Sci. 2013;109:1\u20134. doi: 10.1590/sajs.2013/20120069.", "ArticleIdList": ["10.1590/sajs.2013/20120069"]}, {"Citation": "Roche Diagnostics GmbH  . Introduction of the RTCA DP Instrument. RTCA DP Instrument Operator\u2019s Manual A. ACEA Biosciences Inc.; San Diego, CA, USA: 2008.  [(accessed on 5 February 2024)].  Available online:  http://www.cytometrie-imagerie-saint-antoine.org/media/4046/RTCA_DP_System_Operator_Manual_v3.pdf."}, {"Citation": "Fabre N., Rustan I., de Hoffmann E., Quetin-Leclercq J. Determination of flavone, flavonol, and flavanone aglycones by negative ion liquid chromatography electrospray ion trap mass spectrometry. J. Am. Soc. Mass Spectrom. 2001;12:707\u2013715. doi: 10.1016/S1044-0305(01)00226-4.", "ArticleIdList": ["10.1016/S1044-0305(01)00226-4", "11401161"]}, {"Citation": "Schr\u00f6dinger Release 2020-1: Desmond Molecular Dynamics System. Schr\u00f6dinger; New York, NY, USA: 2020."}, {"Citation": "Schr\u00f6dinger Release 2020-1: Maestro Desmond Interoperability Tools. Schr\u00f6dinger; New York, NY, USA: 2020."}]}], "History": [{"Year": "2024", "Month": "5", "Day": "22"}, {"Year": "2024", "Month": "6", "Day": "10"}, {"Year": "2024", "Month": "6", "Day": "13"}, {"Year": "2024", "Month": "7", "Day": "27", "Hour": "10", "Minute": "45"}, {"Year": "2024", "Month": "7", "Day": "27", "Hour": "10", "Minute": "44"}, {"Year": "2024", "Month": "7", "Day": "27", "Hour": "1", "Minute": "27"}, {"Year": "2024", "Month": "6", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["39065672", "PMC11279959", "10.3390/ph17070821", "ph17070821"]}}]}